CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-14 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +12,850 | $9.37 | $120K | 12,850 |
| 2017-06-14 | JACOBSEN MICHAEL A VP Finance and CAO | Sale | −9,350 | $19.95 | $187K | 3,500 |
| 2017-06-14 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −12,850 | 88,000 | ||
| 2017-06-13 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +2,650 | $9.37 | $25K | 2,650 |
| 2017-06-13 | JACOBSEN MICHAEL A VP Finance and CAO | Sale | −2,650 | $19.95 | $53K | 0 |
| 2017-06-13 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −2,650 | 100,850 | ||
| 2017-04-12 | Cable Thomas J. Director | Sale | −3,000 | $16.49 | $49K | 40,067 |
| 2017-03-20 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +2,040 | $6.05 | $12K | 168,641 |
| 2017-03-20 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −2,040 | 11,000 | ||
| 2017-02-26 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2017-02-26 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2017-02-26 | JACOBSEN MICHAEL A VP Finance and CAO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2016-12-14 | Cable Thomas J. Director | Sale | −3,000 | $10.21 | $31K | 43,067 |
| 2016-12-07 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +102,044 | $0.98 | $100K | 1,987,029 |
| 2016-12-07 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −102,044 | $10.48 | $1.1M | 1,884,985 |
| 2016-12-07 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −102,044 | 0 | ||
| 2016-12-06 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +102,040 | $0.98 | $100K | 1,987,025 |
| 2016-12-06 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −102,040 | $10.80 | $1.1M | 1,884,985 |
| 2016-12-06 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −102,040 | 102,044 | ||
| 2016-12-05 | JACOBSEN MICHAEL A VP Finance and CAO | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 15 of 20 · 391 trades